FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia
The Food and Drug Administration (FDA) expanded the approval of Jylamvo (methotrexate) to include children with acute lymphoblastic...
Nov 5, 2024
Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia
A new study has uncovered molecular markers in blood at birth that are linked to later development of acute lymphoblastic leukemia (ALL),...
Oct 30, 2024
Children with aggressive blood cancer offered treatment cure hope
Youngsters with T-cell acute lymphoblastic leukaemia (T-ALL) will be offered CAR T-cell therapy targeted at a specific protein, which has...
Oct 15, 2024
Radon-Induced Child Cancer Widespread Across US, Even at Low Levels
An analysis of more than 700 counties across the U.S. has uncovered a connection between childhood leukemia and exposure to radon gas ,...
Oct 2, 2024
New research from Children’s Hospital of Philadelphia and St. Jude poised to transform approach to diagnosing and treating acute leukemia in children
Researchers at Children’s Hospital of Philadelphia (CHOP), St. Jude Children’s Research Hospital (St. Jude) and the Children’s Oncology...
Aug 27, 2024
Scientists identify genes linked to relapse in the most common form of childhood leukemia
Researchers identified genetic predictors of relapse in standard risk B-cell acute lymphoblastic leukemia highlighting the role of...
Aug 21, 2024
Pharmacotyping provides a precision medicine blueprint for acute lymphoblastic leukemia treatment
In a report published in Nature Medicine, St. Jude scientists examined how ALL cells respond to different therapeutics in the context of...
Jul 25, 2024
Therapy Shows Promise for Rare Leukemia in Children
Kinase inhibitor trametinib may spare patients from intensive treatments, such as stem cell transplant, for an aggressive form of blood...
Jul 3, 2024
Study identifies high-risk type of childhood acute leukemia and potential treatment strategy
Investigators from St. Jude Children’s Research Hospital and collaborators worldwide have uncovered distinguishing characteristics for a...
Jul 2, 2024
Trametinib Shows Promise for Children with Relapsed or Refractory JMML
The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
Jun 17, 2024